WGS GeneDx Holdings Corp.

NASDAQ
$45.46

GeneDx Holdings Corp. (WGS) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
1
2 transactions
Insiders selling
2
21 transactions
Purchases
$11.1M
200,000 shares
Sales
$3.0M
38,710 shares
Net activity
$8.2M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $3.0M 21 transactions · 38,710 shares

Largest single sale: $406.9K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: June 5, 2026 .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Stueland Katherine 5 fills CHIEF EXECUTIVE OFFICER Sell 10,501 $97.61 $1.0M 124,329 −7.8% of holding
Feeley Kevin 5 fills CHIEF FINANCIAL OFFICER Sell 3,728 $97.61 $363.9K 48,087 −7.2% of holding
Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 3,692 $84.22 $310.9K 107,227 −3.3% of holding
Feeley Kevin CHIEF FINANCIAL OFFICER Sell 1,285 $84.22 $108.2K 41,476 −3% of holding
Stueland Katherine 3 fills CHIEF EXECUTIVE OFFICER Sell 10,501 $60.77 $638.1K 112,733 −8.5% of holding
Feeley Kevin 3 fills CHIEF FINANCIAL OFFICER Sell 3,729 $60.77 $226.6K 42,923 −8% of holding
Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 3,639 $53.77 $195.7K 96,123 −3.6% of holding
Feeley Kevin CHIEF FINANCIAL OFFICER Sell 1,266 $53.77 $68.1K 36,486 −3.4% of holding
Buy 50,000 $52.86 $2.6M 3,707,164
Buy 150,000 $56.44 $8.5M 3,657,164
Feeley Kevin CHIEF FINANCIAL OFFICER Sell 369 $51.74 $19.1K 35,290 −1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.